Buscar
01/01/2026
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis
Marzo-Ortega, H, Harrison, SR, Fragoulis, GE, Michelena, X, Macía-Villa, C, Aydin, SZ, Balanescu, A, Bertheussen, H, Bundy, C, Chimenti, MS, Gisondi, P, Glintborg, B, Gossec, L, Kalyoncu, U, Lubrano, E, Nagy, G, Wagenaar, W, Puig, L, Queiro, R, Rahman, P, Shumnalieva, R, Soriano, ER, van den Bosch, F, Sande, MMGHV, Sepriano, A, Machado, PM, Siebert, S. EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(1)DOI:10.1016/j.ard.2025.10.002. PMID:41168056. IF:20.600(Q1/1D).
01/12/2025
ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa
Grau-Pérez, M, Ciudad, C, Molina-Leyva, A, Martorell, A, Vilarrasa, E, Albert, I, Garcias-Ladaria, J, Melgosa, FJ, Rivera, R, Campos, M, Haselgruber, S, Ochando, G, Pascual, JC, García-Ruiz, R, Alfageme, F. ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. DERMATOLOGY. 2025; 241(5-6)DOI:10.1159/000546647. PMID:40587963. IF:2.700(Q2/4D).
01/12/2025
REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS
Ferrer, AL, Belinchón, I, Serra, MC, Clua, MG, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).
01/12/2025
UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS
Ferrer, AL, Belinchón, I, Serra, MC, Martínez, LE, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).